` Comparison: GLUE vs CANF - Alpha Spread

M
GLUE
vs
C
CANF

Over the past 12 months, GLUE has significantly outperformed CANF, delivering a return of +226% compared to the CANF's 88% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
GLUE
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

GLUE Intrinsic Value
HIDDEN
Show
CANF Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
M
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
18.84 USD
C
Can Fite Biopharma Ltd
TASE:CANF
708 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
GLUE, CANF

GLUE
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
M
Monte Rosa Therapeutics Inc
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
GLUE, CANF

GLUE
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
M
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

GLUE
0%
CANF
0%

Operating Margin

GLUE
4.7%
CANF
-1 487.2%

Net Margin

GLUE
11.5%
CANF
-1 456.2%

FCF Margin

GLUE
79.9%
CANF
-953.8%

ROE

GLUE
9.3%
CANF
-382.9%

ROA

GLUE
5.4%
CANF
-187%

ROIC

GLUE
13.2%
CANF
-6 189.1%

ROCE

GLUE
2.5%
CANF
-273.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
GLUE, CANF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GLUE, CANF

Performance Gap Between GLUE and CANF
HIDDEN
Show

Performance By Year
GLUE, CANF

Loading
GLUE
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare GLUE to other stocks
PNEXF
Pharnext SCA
More expensive
vs GLUE
ABBV
Abbvie Inc
Cheaper
vs GLUE
ATXS
Astria Therapeutics Inc
More expensive
vs GLUE
AMGN
Amgen Inc
Cheaper
vs GLUE
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett